Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

While shares have posted break-even returns so far in 2024, Pfizer stock has cratered by more than 30% over the ...

Laurus Labs' stock, down over 10% from its 52-week high, shows signs of bottoming out. Analysts suggest a buying opportunity ...

Dishant Gupta was director of strategy and operations in the Cambridge office of Ipsen where he learned from co-workers that Ipsen was intent on buying Epizyme in early 2022.

Sage Therapeutics Inc.’s stock tumbled 12.8% early Tuesday, after the company said a mid-stage trial of a treatment for mild ...

ANI Pharmaceuticals acquired Alimera Sciences, boosting its rare disease segment with a couple of durable ophthalmology ...

According to Insider Monkey’s data, 21 hedge funds held stakes in Taysha Gene Therapies, Inc. (NASDAQ:TSHA) as of Q2, with a ...

The pharmaceutical industry is promising due to AI and biotech innovations enhancing productivity, steady profits amidst ...

VanEck Pharmaceutical ETF has shown strong performance but faces near-term downside risks, prompting a rating downgrade to ...

The pharmaceutical industry plays a crucial role in most of our everyday lives. From life-saving medication we need when we ...

We recently made a list of Piper Sandler’s Top Technical Stock Picks: 20 Best Stocks. In this piece, we will look at where ...